Efficacy of mizoribine pulse therapy in patients with rheumatoid arthritis who show a reduced or insufficient response to infliximab

The efficacy of infliximab, a chimeric antibody against tumor necrosis factor-α used to treat patients with rheumatoid arthritis (RA), tends to decrease as patients develop human antichimeric antibody against infliximab (HACA). The clinical study reported here was designed to evaluate the efficacy o...

Descripción completa

Detalles Bibliográficos
Autores principales: Horikoshi, Masanobu, Ito, Satoshi, Ishikawa, Mizue, Umeda, Naoto, Kondo, Yuya, Tsuboi, Hiroto, Hayashi, Taichi, Goto, Daisuke, Matsumoto, Isao, Sumida, Takayuki
Formato: Texto
Lenguaje:English
Publicado: Springer Japan 2009
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689357/
https://www.ncbi.nlm.nih.gov/pubmed/19326186
http://dx.doi.org/10.1007/s10165-009-0162-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689357/
https://www.ncbi.nlm.nih.gov/pubmed/19326186
http://dx.doi.org/10.1007/s10165-009-0162-4

Ejemplares similares